Monashee Investment Management LLC

Position in GPCR — Structure Therapeutics Inc.

CIK 1627608 Boston, MA

Position in GPCR

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$2,410,000

-$13,238,750 QoQ

Shares Held

50,000

-77.8% QoQ

Ownership

0.023%

of shares outstanding

% of Portfolio

1.66%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Monashee Investment Management LLC holds $73,502,476 across 18 Biotechnology names. GPCR ranks #11 (3.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TERN	Terns Pharmaceuticals, Inc.	300,000	$15,816,000
2	SLDB	Solid Biosciences Inc.	1,420,295	$10,226,124
3	NKTR	Nektar Therapeutics	100,000	$7,195,000
4	CYTK	Cytokinetics Inc	100,000	$6,591,000
5	BBIO	BridgeBio Pharma, Inc.	67,139	$4,985,742
6	EVMN	Evommune, Inc.	179,340	$4,123,026
7	MANE	Veradermics, Inc	50,000	$3,157,500
8	ZBIO	Zenas BioPharma, Inc.	150,000	$2,932,500

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,410,000	50,000	-77.8%	Shares	Sole	2026-05-13
2025-12-31	$15,648,750	225,000	+12.5%	Shares	Sole	2026-02-12
2025-09-30	$5,600,000	200,000	-53.5%	Shares	Sole	2025-11-12
2025-06-30	$8,918,200	430,000	+46.8%	Shares	Sole	2025-08-11
2025-03-31	$5,069,441	292,862	+121.9%	Shares	Sole	2025-05-14
2024-12-31	$3,579,840	132,000	-17.3%	Shares	Sole	2025-02-14
2024-09-30	$7,005,195	159,608	+219.2%	Shares	Sole	2024-11-12
2024-06-30	$1,963,500	50,000	-47.2%	Shares	Sole	2024-08-12
2024-03-31	$4,059,442	94,714	-50.6%	Shares	Sole	2024-05-14
2023-12-31	$7,820,009	191,855	-69.7%	Shares	Sole	2024-02-12
2023-09-30	$31,954,481	633,766	-53.8%	Shares	Sole	2023-11-13
2023-06-30	$56,992,095	1,370,991	+706.5%	Shares	Sole	2023-08-10
2023-03-31	$4,044,300	170,000	—	Shares	Sole	2023-05-05
No filing history on record for this holder in this stock.